Scheduled Maintenance Notice
Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.
Select Publications
Preprints
, A pragmatic stepped wedge cluster randomised implementation trial assessing the effect of a quality improvement programme on the proportion of infants achieving delayed cord clamping for more than 60 seconds in infants <37 weeks gestation: Statistical analysis plan for the Wait a Minute or More (WAMM) trial, http://dx.doi.org/10.21203/rs.3.rs-8876192/v1
, Epidemiology of early- and late-onset serious bacterial infections in Australian neonates and infants: A retrospective multicentre study, http://dx.doi.org/10.1101/2024.12.14.24318949
, Postoperative noninvasive ventilation and complications after repair of oesophageal atresia-tracheoesophageal fistula (OA-TOF): a retrospective chart review, http://dx.doi.org/10.21203/rs.3.rs-2680193/v1
, Reference values for diaphragm electrical activity (Edi) in newborn infants, http://dx.doi.org/10.22541/au.162514165.52117415/v1
, Reference Values For Diaphragm Electrical Activity (Edi) In Newborn Infants, http://dx.doi.org/10.21203/rs.3.rs-1387574/v1
, Standardised neonatal parenteral nutrition formulations – Australasian Neonatal Parenteral Nutrition Consensus update 2017, http://dx.doi.org/10.21203/rs.2.17165/v2
, Standardised neonatal parenteral nutrition formulations – Australasian Neonatal Parenteral Nutrition Consensus update 2017, http://dx.doi.org/10.21203/rs.2.17165/v1
, Standardised neonatal parenteral nutrition formulations – Australasian Neonatal Parenteral Nutrition Consensus update 2017, http://dx.doi.org/10.21203/rs.2.17165/v3
, Variation in clinical practice guidelines for use of palivizumab in preventing severe respiratory syncytial viral (RSV) disease in high-risk infants, http://dx.doi.org/10.22541/au.166419726.62754781/v2
, Variation in clinical practice guidelines for use of palivizumab in preventing severe respiratory syncytial viral (RSV) disease in high-risk infants, http://dx.doi.org/10.22541/au.166419726.62754781/v1